The safety and immunogenicity of a new tuberculosis (TB) vaccine, MVA85A, in healthy volunteers who are infected with human immunodeficiency virus (HIV): an open label phase I study.

Trial Profile

The safety and immunogenicity of a new tuberculosis (TB) vaccine, MVA85A, in healthy volunteers who are infected with human immunodeficiency virus (HIV): an open label phase I study.

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Jan 2014

At a glance

  • Drugs MVA 85A (Primary)
  • Indications Tuberculosis
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 19 Dec 2009 The Wellcome Trust added as trial sponsor as reported by ISRCTN: Current Controlled Trials.
    • 19 Dec 2009 New source identified and integrated (ISRCTN: Current Controlled Trials, 34189114).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top